- Breakthrough COVID-19 in people with Rheumatic Disease
- Patients with rheumatic and musculoskeletal diseases had higher rates of SARS-CoV-2 infection and increased odds of death
- Vaccine perceptions among people with rheumatic disease
- COVID-19 Pandemic Impact on Rheumatic Patients’ Health, Healthcare Utilization, and Behaviors
- COVID-19 When Pregnant and Living with a Rheumatic Disease
- Survey of COVID-19 vaccination experiences in patients with systemic rheumatic disease
- Tumor Necrosis Factor Inhibitors and COVID-19 related hospitalization and death in patients suffering from immune-mediated inflammatory disease
- The risk of severe COVID-19 outcomes for people with vasculitis or polymyalgia rheumatica
- Plain Language Summary for a study that shows the associations between b/tsDMARDs, taken by rheumatoid arthritis (RA) patients, and the severity of their COVID-19 illness outcomes
- Plain Language Summary of Characteristics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry (added 15 July 2021)
- Plain Language Summary of Medications Impacting Response to COVID-19 Vaccines (added 23 April 2021)
- Plain Language Summary of Factors Associated with COVID-19 Related Death for People with Rheumatic Disease (added 5 February 2021)
- Original Article: Strangfeld A, Schäfer M, Gianfrancesco MA, et al. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. [published online ahead of print 27 January 2021]. doi: 10.1136/annrheumdis-2020-219498
- Version of this article posted on the BMJ Rheumatology patient summaries blog: https://blogs.bmj.com/rheumsummaries/2021/02/09/covid-19-related-death-in-rheumatic-diseases/
- Plain Language Visual Abstract of our #ACR20 Abstract 6: Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US
- Plain Language Summary of COVID-19 Global Rheumatology Alliance’s First Provider-Reported Data Analysis
- Original Article: Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals of the Rheumatic Diseases. [Epub ahead of print 29 May 2020]. doi: 10.1136/annrheumdis-2020-217871
- Efficacy of Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis of the Current Evidence
- Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases
- Original Article: Gianfrancesco M, Yazdany J, Robinson PC. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases [published online ahead of print, 2020 Jul 15]. Curr Opin Rheumatol. 2020;10.1097/BOR.0000000000000725. doi: 10.1097/BOR.0000000000000725
- Plain Language Summary of COVID-19 and Hydroxychloroquine
- Plain Language Summary of Race/Ethnicity association with COVID-19 Outcomes in Rheumatic Disease
- Original Article: Milena A. Gianfrancesco et al. on behalf of the COVID‐19 Global Rheumatology Alliance. [published online ahead of print, 03 November 2020].Race/ethnicity association with COVID‐19 outcomes in rheumatic disease: Data from the COVID‐19 Global Rheumatology Alliance Physician Registry. Arthritis & Rheumatology (2020) doi: https://doi.org/10.1002/art.41567
English
Afrikaans
العربية
简体中文
Dansk
Nederlands
Filipino
Français
Deutsch
עִבְרִית
Íslenska
Italiano
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Русский
Gàidhlig
Español
Svenska
ไทย
